Key Highlights of the Report: New pathogens and rising rates for multidrug-resistant (MDR) treatable infections guarantee the need for new antibiotics and therapeutics. For new antibiotics, other treatments, and quick diagnostic systems, pharmaceutical and biotechnology businesses are spending on research and development. There is an increasing emphasis placed on the creation of products for...

According to a new report by UnivDatos, the Antibiotic Resistance Market is expected to reach ~USD 13.32 billion in 2032 by growing at a CAGR of ~5.4%. Antimicrobial resistance is a very sensitive and evolving threat within the healthcare market and is indicated by the emergence of multidrug-resistant organisms, to which standard antibiotics are ineffective. These increased rates...